Geneva Cancer Registry

This interactive dashboard serves as a living observatory of cancer in Geneva's canton, enabling patients, clinicians, researchers and policymakers to quickly explore up-to-date incidence and mortality indicators by tumour site, gender, year.

Each year in Geneva: *

Data extraction date: 27.08.2026
Application update date: 28.09.2026

User guide

Download the complete user guide for this dashboard.

The guide is currently available in French only.

Download the user guide (PDF)

Overall epidemiology

Note: non-melanoma skin cancers (C44) are excluded from this summary page, and figures apply IARC multiple primary rules (one tumour counted per organ/site per patient).


The Others category is kept in tables and CSV exports but is not shown as a separate bar in this chart.

<5 : 1 to 4 cases over the chosen period (0 is shown as 0). Site totals are replaced by - when any selected behaviour for that site has 1–4 cases, so the masked count cannot be recovered by subtraction.
Cancer sites with fewer than 5 total cases over the selected period (for the selected sex) are merged into the Others category. This threshold is based on total cases, not on annual averages.

Cancer sites with fewer than 5 total cases over the selected period (for the selected sex) are merged into the Others category. This threshold is based on total cases, not on annual averages.
Cancer sites with fewer than 5 cases in any year of the selected period (for the selected sex, sum of selected behaviours) are merged into Others for all years. For consistency with Top N selection, sites ranked in the Top N of the latest selected year remain displayed as separate bands.

Behaviour-specific counts of 1–4 are displayed as <5 (0 is shown as 0). When several behaviours are selected, a Total row is shown and highlighted as the series drawn on the chart. If any behaviour for that site has 1–4 cases, the Total is shown as -. Sites merged into Others follow the chart rule above.

Age groups with fewer than 5 cases over the entire period are not displayed in the chart (bars are omitted).

Age groups with fewer than 5 cases over the entire period are displayed as <5 in the table.

Note: Only cancer sites with at least 5 cases for each period are included.


Site–period points with 1–4 cases are omitted from the chart. In the table, those counts and linked indicators (median age, crude rate, ASR, selected indicator) are shown as <5 (0 remains 0).

Site–period points with 1–4 cases are omitted from the chart. In the table, those counts and linked indicators (median age, crude rate, ASR, selected indicator) are shown as <5 (0 remains 0).


Important : evolution shown only if the selected site has at least 5 cases in each 3-year period (for the selected sex).


<5 : 1 to 4 cases over the chosen period (0 is shown as 0). Site totals are replaced by - when any selected behaviour for that site has 1–4 cases, so the masked count cannot be recovered by subtraction.

Important : Ranks are computed for each 5-year period. Click the site whose rank evolution you want to see (site colour); other sites stay grey. Sites outside the Top N are shown in the '+' row.



<5 : 1 to 4 cases over the chosen period (0 is shown as 0). Site totals are replaced by - when any selected behaviour for that site has 1–4 cases, so the masked count cannot be recovered by subtraction.

Important : Observed points remain displayed even when a year has fewer than 5 cases (the hover label then shows <5; the rate is kept). Joinpoint curves and the statistics table are shown only for series that meet the 5-case rule (at most 3 years below this threshold, for the selected sex).


Note: Points are hidden when fewer than 5 cases are observed in the 3-year period for the selected age group.


⚠ Important: The APC assumes linear trends between the two periods. Interpret with caution if trends are non-linear. Sites with fewer than 5 cases in either period are excluded from the chart and table.


Note: APC models require sufficient cases across age and period cells. Results should be interpreted together with the deviance table.



Model comparison (deviance table)


Input table (cases and person-years)

Note: Observed age-specific rates are plotted against year of birth (period minus age). This descriptive view does not estimate an APC model.


This page provides a concise overview of the cancer burden in Geneva through key incidence and mortality indicators for each selected cancer site, considered independently from the others.

Key Indicators

Cancer site
Incidence (invasive)
Mortality
Mortality-to-Incidence Ratio (MIR)
population-level lethality proxy
0% (favourable) 100% (unfavourable)
Incidence profile
Median age at diagnosis
Mortality profile
Median age at death
Incidence rate
Mortality rate
Mean annual incidence counts
Peak age group
Share aged <50
Mean annual mortality counts
Peak age group
Share aged <65
Explore Geneva cancer data

More detailed information for each cancer type will be available soon.

Multiple primaries (Incidence)



Note: Original cases (recording) count all registered tumours of all behaviours. Included cases (reporting) exclude multiple primary tumours according to IARC rules. Exclusions add up duplicates across all behaviours. Values are aggregated over 5-year periods.